Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹80 Cr.
Stock P/E
-32.3
P/B
3.3
Current Price
₹117.4
Book Value
₹ 35.8
Face Value
10
52W High
₹293
52W Low
₹ 103.1
Dividend Yield
0%

Maitreya Medicare Overview

Business

Maitreya Medicare Ltd. is an India-based company operating a multi-specialty hospital in Surat, Gujarat. The company provides comprehensive healthcare services across various medical disciplines including Cardiology, Urology, Oncology, Neurosurgery, Gastroenterology, Orthopedics, Critical Care, and others. Its core business model revolves around providing both in-patient (IPD) and out-patient department (OPD) services, surgical procedures, diagnostic services (pathology, radiology), and pharmacy services. The company generates revenue primarily from medical treatments, surgeries, consultations, diagnostics, and pharmaceutical sales to patients.

Revenue Mix

Maitreya Medicare operates as an integrated multi-specialty hospital, so a detailed breakdown of revenue by specific medical specialty is typically not disclosed for a company of this size. However, its revenue streams generally comprise:

In-patient Department (IPD) Services: Revenue from patients admitted for treatments, surgeries, and extended care. This is generally the larger contributor for hospitals.

Out-patient Department (OPD) Services: Revenue from consultations, minor procedures, and follow-ups.

Diagnostic Services: Income from pathology, radiology (X-ray, ultrasound, CT/MRI scans), and other diagnostic tests.

Pharmacy & Other Services: Revenue from in-house pharmacy sales and other allied medical services.

Industry

The Indian hospital and healthcare services industry is characterized by a mix of public and private players, with private hospitals dominating specialized and advanced care. It is highly fragmented, especially at the regional level, but is undergoing consolidation. Maitreya Medicare operates a single 120-bed multi-specialty hospital in Surat, Gujarat. Its positioning is as a regional player focusing on providing comprehensive and advanced medical services within its locality. It competes with other private hospitals, nursing homes, and potentially larger hospital chains that may have a presence or are expanding into tier-2 cities like Surat.

MOAT

For a regional multi-specialty hospital like Maitreya Medicare, competitive advantages typically stem from:

Local Brand Reputation: A strong reputation within its catchment area built over years through patient outcomes, doctor expertise, and service quality.

Doctor Relationships: A network of experienced and reputable doctors affiliated with the hospital, attracting patients.

Operational Efficiency: Efficient management of bed occupancy rates, surgical schedules, and resource utilization.

Established Infrastructure: Modern medical equipment and infrastructure in a growing region.

However, these are often localized and can be challenged by new entrants or expanding larger chains. A strong, wide moat is difficult to establish for a single-unit regional hospital.

Growth Drivers

Rising Healthcare Demand: Increasing population, growing disposable incomes, rising health awareness, and the burden of lifestyle diseases in India.

Medical Tourism (Domestic): Growth in patients traveling from smaller towns/rural areas to cities for specialized treatments.

Increased Insurance Penetration: Government schemes (e.g., Ayushman Bharat) and private health insurance are making healthcare more accessible and affordable, leading to higher utilization.

Expansion & Specialization: Potential for increasing bed capacity, adding more specialized services, or exploring new facilities in strategic locations.

Technological Advancements: Adoption of new medical technologies and procedures can attract more patients and improve treatment outcomes.

Risks

Intense Competition: Highly competitive market with existing regional players and potential entry of larger hospital chains.

Doctor Retention: Reliance on key medical professionals; their departure could impact service quality and patient flow.

Regulatory Risks: Government policies related to pricing controls on drugs/medical devices or treatment costs could impact profitability.

Operational Challenges: Maintaining high bed occupancy rates, managing operational costs, and ensuring efficient resource utilization.

Funding for Expansion: Future growth plans may require significant capital expenditure, which could pose financial risks if not managed effectively.

Reputational Risk: Any adverse events, medical errors, or negative publicity can severely impact patient trust and revenue.

Management & Ownership

Maitreya Medicare Ltd. is promoted by Dr. Vimal N. Mulia, Dr. Rajnikant N. Mulia, and Mrs. Pramilaben N. Mulia. Dr. Vimal N. Mulia serves as the Chairman & Managing Director, bringing medical expertise and strategic leadership. Dr. Rajnikant N. Mulia is also a promoter and Whole-Time Director. The management team includes other professionals in finance and operations. As an SME IPO-listed company, a significant portion of the ownership typically remains with the promoter group, indicating concentrated control and direct involvement in operations.

Outlook

Maitreya Medicare operates in a fundamentally growing Indian healthcare market, driven by demographic trends and increasing healthcare spending. Its established presence and multi-specialty offerings in Surat position it to benefit from regional demand. The hospital's focus on a wide range of specialties caters to diverse patient needs, potentially supporting stable revenue streams. However, as a single-unit, regional player, it faces significant competition from both local hospitals and larger, well-funded corporate chains. Its ability to expand sustainably, attract and retain top medical talent, manage operational costs effectively, and adapt to evolving regulatory landscapes will be crucial. The outlook is cautiously optimistic, dependent on the company's execution capabilities in a competitive and capital-intensive industry.

Maitreya Medicare Share Price

Live · NSE · Inception: 2019
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Maitreya Medicare Quarterly Results

#(Fig in Cr.) Dec 2022 Mar 2023 Dec 2023 Mar 2024
Net Sales 9 11 12 12
Other Income 0 0 0 0
Total Income 9 12 12 13
Total Expenditure 8 8 9 13
Operating Profit 0 4 3 -1
Interest 0 0 0 0
Depreciation 0 0 0 0
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax -0 3 2 -1
Provision for Tax -0 1 1 -0
Profit After Tax -0 2 2 -1
Adjustments 0 0 0 0
Profit After Adjustments -0 2 2 -1
Adjusted Earnings Per Share -0 4.6 2.3 -1.6

Maitreya Medicare Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 57 49 39 48 47 45 44
Other Income 0 0 1 0 1 1 0
Total Income 57 50 40 48 47 46 46
Total Expenditure 49 46 32 42 42 45 38
Operating Profit 8 4 8 6 5 1 6
Interest 1 1 1 1 1 1 0
Depreciation 1 1 1 1 1 2 0
Exceptional Income / Expenses 0 0 -0 0 0 -0 0
Profit Before Tax 6 2 6 4 3 -2 4
Provision for Tax 2 0 2 1 1 0 2
Profit After Tax 4 1 4 3 2 -2 3
Adjustments 0 0 0 0 0 0 0
Profit After Adjustments 4 1 4 3 2 -2 3
Adjusted Earnings Per Share 8.6 2.3 8 3.9 2.7 -3.6 5.3

Maitreya Medicare Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 9 10 15 30 32 29
Minority's Interest 1 1 1 0 1 1
Borrowings 8 6 6 4 4 22
Other Non-Current Liabilities 0 1 1 1 1 1
Total Current Liabilities 7 7 7 8 11 16
Total Liabilities 25 24 29 44 48 68
Fixed Assets 14 13 12 14 15 41
Other Non-Current Assets 1 2 4 4 5 4
Total Current Assets 11 9 14 25 28 23
Total Assets 25 24 29 44 48 68

Maitreya Medicare Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1 2 1 2 7 8
Cash Flow from Operating Activities 4 0 3 -3 5 8
Cash Flow from Investing Activities -5 -0 0 -5 -7 -27
Cash Flow from Financing Activities 2 -2 -2 12 4 19
Net Cash Inflow / Outflow 2 -2 1 4 1 0
Closing Cash & Cash Equivalent 2 1 2 7 8 8

Maitreya Medicare Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 8.56 2.29 7.98 3.86 2.68 -3.64
CEPS(Rs) 10.75 4.96 11.18 6.26 4.89 -1.39
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 7.79 9.5 17.68 36.67 39.43 35.79
Core EBITDA Margin(%) 12.8 6.81 18.41 12.56 10.47 -0.72
EBIT Margin(%) 11.64 4.8 16.49 10.53 8.49 -2.04
Pre Tax Margin(%) 10.19 3.23 15.05 8.76 6.76 -5.37
PAT Margin (%) 7.5 2.3 10.8 6.22 3.9 -5.5
Cash Profit Margin (%) 9.42 4.98 14.08 8.88 7.1 -2.1
ROA(%) 16.79 4.57 15.93 8.16 3.96 -4.23
ROE(%) 109.87 26.51 63.08 17.67 7.05 -9.67
ROCE(%) 36.39 13.48 34.68 17.86 10.82 -2.04
Receivable days 31.53 39.76 72.33 89.52 112.06 105.71
Inventory Days 8.8 7.58 6.88 5.37 4.69 5.84
Payable days 194.22 144.65 279.58 194.79 178.01 158.04
PER(x) 0 0 0 30.85 113.88 0
Price/Book(x) 0 0 0 3.25 7.75 5
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0.2 0.23 0.37 1.78 4.49 3.13
EV/Core EBITDA(x) 1.48 3.04 1.87 13.58 38.42 211.82
Net Sales Growth(%) 0 -12.72 -20.3 21.29 -2.31 -3.88
EBIT Growth(%) 0 -63.99 173.72 -22.57 -21.25 -123.07
PAT Growth(%) 0 -73.22 274.24 -30.17 -38.77 -235.6
EPS Growth(%) 0 -73.22 248.28 -51.66 -30.43 -235.6
Debt/Equity(x) 1.03 0.78 0.4 0.19 0.16 0.8
Current Ratio(x) 1.47 1.28 1.99 2.99 2.58 1.47
Quick Ratio(x) 1.28 1.32 1.87 3.6 3.78 3.56
Interest Cover(x) 8.06 3.05 11.44 5.96 4.92 -0.61
Total Debt/Mcap(x) 0 0 0 0.07 0.03 0.19

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -4% +5% -5% —
Operating Profit CAGR -80% -50% -34% —
PAT CAGR -200% 0% 0% —
Share Price CAGR -50% — — —
ROE Average -10% +5% +21% +36%
ROCE Average -2% +9% +15% +19%

Maitreya Medicare Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 73.11 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 26.89 %
# Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
Promoter 73.1173.1173.1173.1173.11
FII 2.530.410.010.010
DII 1.350000
Public 23.0226.4826.8826.8826.89
Others 00000
Total 100100100100100

Maitreya Medicare Peer Comparison

Hospital & Healthcare Services Edit Columns

Maitreya Medicare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Maitreya Medicare Pros & Cons

Pros

  • Debtor days have improved from 178.01 to 158.04days.

Cons

  • Company has a low return on equity of 5% over the last 3 years.
  • Stock is trading at 3.3 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp